Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
beneficial, CAPTIVATE, commenced, decided, discontinue, dual, earlier, glomerulopathy, hazard, Healthcare, hemoglobinuria, imminent, immunoglobulin, imposed, inhibition, mechanism, middle, MSD, nephropathy, nocturnal, paroxysmal, poly, polymerase, pretreated, priority, proceed, pulmonary, radiographic, schizophrenia, Scotiabank, screening, slightly, stabilization, Talzenna, tulmimetostat, urinary
Removed:
gain, legally, receipt, wholly
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view